ARCHIVES

In Brief: Evaluation Of Potential Immunoassay Components Sought; Promising Results Could Lead to Contract

This article is from The Cancer Letter archive.

Vol. 01 No. 38 | September 19, 1975

Download PDF Visit The Full Archive

Related Articles

Vasopermeation Technology Awarded Patent For CA Firm.

September 28, 2001

Take Program Direction Away From CCIRC, Form New Group for Clinical Trials, Conferees Suggest

June 6, 1975

Erbitux Plus Chemo Effective For NSCLC; Carboplatin Prevents Testicular Recurrence

July 25, 2008

Commission Urges Bypass Funding for Breast Cancer

November 5, 1993

In Congress: NCI Apologizes For Delay In Report On Radioactive Fallout

September 18, 1998

Unclear Whether Insurance Will Cover AACR Losses

April 25, 2003